February 19, 2021 Portfolio News from ARCH Venture Partners | Share 908 Devices Stock More Than Doubles in Market Debut
February 12, 2021 Portfolio News from ARCH Venture Partners | Share Encodia Closes $75M Series C Financing
February 4, 2021 Portfolio News from ARCH Venture Partners | Share Sana Snags $587.5M IPO to Catapult Cell Therapies into the Clinic
January 28, 2021 ARCH News from ARCH Venture Partners | Share ARCH Venture Partners Announces New $1.85 Billion Fund to Create and Fund Early Stage Biotechnology Companies
December 1, 2020 Portfolio News from ARCH Venture Partners | Share Resilience – Raging at the Pandemic, a VC raises $800M for a Company That Aims to Transform Biotech Manufacturing
December 1, 2020 Media Coverage from ARCH Venture Partners | Share Co-Founder and Managing Director, Robert Nelsen, on AstraZeneca and His Plan to Revolutionize Biotech
July 30, 2020 Media Coverage from ARCH Venture Partners | Share Co-Founder and Managing Director, Robert Nelsen, Discusses Commitment to Infectious Disease Investing and its Implications amid COVID-19
July 15, 2020 Portfolio News from ARCH Venture Partners | Share Beam Therapeutics – This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect
June 2, 2020 Portfolio News from ARCH Venture Partners | Share Vir – Antibody from SARS Survivor Neutralizes SARS-CoV-2 Live Virus Infection of Cells
June 2, 2020 Portfolio News from ARCH Venture Partners | Share Mindstrong Raises $100M in Series C Round of Financing
April 27, 2020 Portfolio News from ARCH Venture Partners | Share Rome Therapeutics Launches with $50M to Tackle Small-Molecule Drugs for Cancer
